Sustained Response to Anti-CD20 Monoclonal Antibody in Severe Acute Primary Immune Thrombocytopenic Purpura: Report of One Adult Case

Abstract

References

Howard J , Hoffbrand AV , Prentice HG , Mehta A . Mycophenolate mofetil for the treatment of refractory autoimmune haemolytic anemia and autoimmune thrombocytopenic purpura. Br J Haematol 2002;117:712.

Stasi R , Pagano A , Stipa E , Amadori S . Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001;98:952.

Delgado J , Bustos JG , Jimenez-Yuste V , Hernandez-Navarro F . Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura. Haematologica 2002;87:215.

Zaja F , Vianelli N , Sperotto A , et al. The B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica 2003;88:538.

Cooper N , Stasi R , Cunningham-Rundles S , et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 2004;125:232.